The female condom.

A female condom has been developed which is effective in preventing pregnancy and sexually transmitted diseases (STDs), including HIV infections. The condom is a soft, loose-fitting polyurethane sheath which has a closed inner ring which covers the cervix and an open outer ring, which protrudes visibly from the vagina and covers the labia. The female condom may be more effective than the male condom in preventing transmission of HIV and herpes. The polyurethane is stronger and probably less likely to tear than the latex used in male condoms. In a 6-month trial of use in 240 US women, 12.4% became pregnant with "typical" use and 2.6% with "perfect" use. These rates are comparable with other female barrier contraceptives. Some aspects of the female condom are unacceptable to some women, including the protrusion from the vagina and the fact that it covers the clitoris. Other women found that the device enhanced clitoral sensation. Problems with the condom being pushed into the vagina or pulled out during intercourse may be addressed by the application of additional lubrication. A substantial number of users reported that the female condom was an acceptable method of contraception. It is the only female-controlled contraceptive which provides protection against pregnancy and STDs. It will cost approximately US $1.25 for family planning clinics and $2.50 for individuals.